T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly
Erişim
info:eu-repo/semantics/closedAccessTarih
2021Yazar
Akkaya, E.Akgun, M.Y.
Sebnem Durmaz, E.
Aydın, S.
Mefkure Ozkaya, H.
Comunoglu, N.
Kizilkilic, O.
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Any preoperative diagnostic assessment that can predict the success of the operation in acromegaly will provide a positive impact on overall remission rates. The aim of this study is to reveal whether the signal intensity in T2-weighted Magnetic Resonance Imaging can predict postoperative results in acromegaly patients with macroadenoma. Methods: We analyzed our surgical results in regard to T2-weighted images in newly diagnosed consecutive 124 patients with acromegaly, operated between 2014 and 2019. The T2-intensity of the pure somatotroph macroadenomas was correlated with the clinical, radiological, surgical and histopathological characteristics of the acromegaly patients. Results: We found a predominance of T2-hyperintensity in our series (45%) and the T2-hypointense pure somatotroph adenomas were detected in only 34% of our patients. Total resection was performed in 72% of newly diagnosed acromegaly patients in this series. Accordingly, total resection was achieved in 69% of the T2-hyperintense group, 77% of the T2-hypointense group and 69% of the T2-isointense group. The surgical remission rates for the T2-hyper-, hypo- and isointense groups were 54.5%, 80.7%, and 68.7%, respectively. The surgical remission rate in the T2-hyperintense group was significantly lower than those of hypo- and isointense groups in newly diagnosed acromegaly patients. Conclusions: This study demonstrates a close relationship between the T2 signal intensity and the surgical remission rates in acromegaly patients with macroadenoma. Preoperative T2-intensity images may predict the probability of post-surgical remission in patients with newly diagnosed acromegaly. Further support fort this idea comes from recent guidelines for acromegaly management in which the potential utility of using T2 intensity to optimize patient management has been emphasized. © 2021 Elsevier Ltd
Kaynak
Journal of Clinical NeuroscienceCilt
90Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features
Durcan E.; Keskin F.E.; Ozkaya H.M.; Sirolu S.; Sahin S.; Korkmaz O.P.; Gazioglu N. (Georg Thieme Verlag, 2022)Purpose To investigate the relationship of Fibroblast Growth Factor Receptor-4 (FGFR-4) expression with radiologic, pathologic, and clinical parameters in pituitary adenomas. Methods Among 307 patients who underwent pituitary ... -
G-protein Coupled Estrogen Receptor Expression in Growth Hormone Secreting and Non-Functioning Adenomas
Ozkaya, H.M.; Sayitoglu, M.; Comunoglu, N.; Sun, E.; Keskin, F.E.; Ozata, D.; Kadioglu, P. (Georg Thieme Verlag, 2021)Purpose To evaluate the expression of G-protein coupled estrogen receptor (GPER1), aromatase, estrogen receptor α (ERα), estrogen receptor β (ERβ), pituitary tumor transforming gene (PTTG), and fibroblast growth factor 2 ... -
Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia
Azamat, S.; Betul Arslan, D.; Erdogdu, E.; Kicik, A.; Cengiz, S.; Eryürek, K.; Tufekcioglu, Z. (Elsevier Ireland Ltd, 2021)Mild cognitive impairment of Parkinson's disease (PD) may be an early manifestation that may progressively worsen to dementia. Cognitive decline has been associated with changes in the brain perfusion pattern. This study ...